Evidence map›Paper›PMID 32517067›Full record

ReviewNanomaterials (Basel, Switzerland)2020

Emerging Nano/Micro-Structured Degradable Polymeric Meshes for Pelvic Floor Reconstruction.

Kallyanashis Paul, Saeedeh Darzi, Jerome A Werkmeister, Caroline E Gargett, Shayanti Mukherjee

Open access · goldAbstract readReview
In one paragraph

Review in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Chapter 4.5: New Proposed Treatments for Pelvic Organ Prolapse.International urogynecology journal · 2026
    Review
  4. Review
  5. Article
  6. Sacrocolpopexy: Alternatives to Mesh Grafts.International urogynecology journal · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Endometrial SUSD2Journal of personalized medicine · 2021
    Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kallyanashis PaulThe Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.ORCID 0000-0002-0953-3263
Saeedeh DarziThe Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.
Jerome A WerkmeisterThe Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.
Caroline E GargettThe Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.ORCID 0000-0002-3590-2077
Shayanti MukherjeeThe Ritchie Centre, Hudson Institute of Medical Research, Clayton 3168, Australia.ORCID 0000-0001-9995-002X
Hudson Institute of Medical Research · AU

Funding

International Postgraduate Research Training and Monash Graduate Scholarships Not applicableNational Health and Medical Research Council 1184841, 1173882, 1159677
6 · The paper itself

Abstract

Pelvic organ prolapse (POP) is a hidden women's health disorder that impacts 1 in 4 women across all age groups. Surgical intervention has been the only treatment option, often involving non-degradable meshes, with variable results. However, recent reports have highlighted the adverse effects of meshes in the long term, which involve unacceptable rates of erosion, chronic infection and severe pain related to mesh shrinkage. Therefore, there is an urgent unmet need to fabricate of new class of biocompatible meshes for the treatment of POP. This review focuses on the causes for the downfall of commercial meshes, and discusses the use of emerging technologies such as electrospinning and 3D printing to design new meshes. Furthermore, we discuss the impact and advantage of nano-/microstructured alternative meshes over commercial meshes with respect to their tissue integration performance. Considering the key challenges of current meshes, we discuss the potential of cell-based tissue engineering strategies to augment the new class of meshes to improve biocompatibility and immunomodulation. Finally, this review highlights the future direction in designing the new class of mesh to overcome the hurdles of foreign body rejection faced by the traditional meshes, in order to have safe and effective treatment for women in the long term.

Indexed as

3D printing foreign body responsecell therapymesh complicationsnanofiber meshpelvic organ prolapsetissue engineering

Identifiers

PMID32517067
PMCPMC7353440
OpenAlexW3033447363

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.